- Why Vaccine Makers Could Benefit From Mandates (Barron’s)
- Chinese Stocks Jump as Beijing Signals More Economic Support (Bloomberg)
- Pfizer and Moderna ramp up EU Covid vaccine prices (Financial Times)
- Proxy Season Is Winding Down, but Activist Opportunities Still Abound (Barron’s)
- Li Auto Posts Huge Deliveries. Good News for EVs as Chip Shortage Abates. (Barron’s)
- The Cost of Becoming an Olympic Swimmer for Team USA (Wall Street Journal)
- Behind the Rise of U.S. Solar Power, a Mountain of Chinese Coal (Wall Street Journal)
- Eviction Ban’s Expiration Leaves Renters in South Appearing Most Vulnerable (Wall Street Journal)
- Tide of U.S. Debt Set to Recede, Countering Effect of Fed Taper (Bloomberg)
- Nuclear Power Could Get Lifeline in Senate Infrastructure Bill (Bloomberg)
- FDA Under Pressure to Grant Full Approval to Covid-19 Vaccines (Wall Street Journal)
- Senate unveils $1 trillion bipartisan infrastructure bill, vote expected within days (MarketWatch)
- Ray Dalio says Chinese stocks still ‘important part’ of a portfolio after crackdown (MarketWatch)
- ‘A great time to buy,’ says one Wall Street analyst as Amazon shares tumble on disappointment (MarketWatch)
- Brazil manufacturing PMI rises to 5-month high in July, IHS Markit says (Reuters)